KPRX
Price:
$2.55
Market Cap:
$11.30M
Kiora Pharmaceuticals, Inc., a specialty pharmaceutical firm operating at the clinical stage, is dedicated to the creation and commercialization of treatments for various ophthalmic conditions across the United States. Its flagship therapeutic candidate, KIO-301, is a groundbreaking small molecule undergoing Phase 1 clinical trials. This innovative "photoswitch" aims to revitalize vision in individuals suffering from both inherited and age-related forms of retinal degeneration. The company's pipeline also includes KIO-101, an eye drop currently in Phase 2 trials for addressing the ocular manifestations of rheumatoid arthritis, as well as non-infectious posterior uveitis. Furthermore, Kiora i...[Read more]
Industry
Biotechnology
IPO Date
2015-02-13
Stock Exchange
NASDAQ
Ticker
KPRX
According to Kiora Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 719.67K. This represents a change of -80.89% compared to the average of 3.77M of the last 4 quarters.
The mean historical Enterprise Value of Kiora Pharmaceuticals, Inc. over the last ten years is 103.16M. The current 719.67K Enterprise Value has changed -30.24% with respect to the historical average. Over the past ten years (40 quarters), KPRX's Enterprise Value was at its highest in in the March 2021 quarter at 323.69M. The Enterprise Value was at its lowest in in the March 2026 quarter at -2524405.14.
Average
103.16M
Median
124.70M
Minimum
-119927.76
Maximum
283.17M
Discovering the peaks and valleys of Kiora Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 4.90%
Maximum Annual Enterprise Value = 283.17M
Minimum Annual Increase = -101.33%
Minimum Annual Enterprise Value = -119927.76
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | -119927.76 | -101.33% |
| 2024 | 9.04M | 4.90% |
| 2023 | 180.84K | -98.92% |
| 2022 | 16.75M | -86.43% |
| 2021 | 123.42M | -39.24% |
| 2020 | 203.11M | -28.27% |
| 2019 | 283.17M | 101.50% |
| 2018 | 140.53M | 8.49% |
| 2017 | 129.53M | 2.81% |
| 2016 | 125.99M | -12.27% |
The current Enterprise Value of Kiora Pharmaceuticals, Inc. (KPRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
3.04M
5-year avg
29.85M
10-year avg
103.16M
Kiora Pharmaceuticals, Inc.’s Enterprise Value is greater than Aprea Therapeutics, Inc. (-42010310.00), less than BioCardia, Inc. (4.56M), greater than Acurx Pharmaceuticals, Inc. (-6766398.00), greater than IN8bio, Inc. (-12958522.00), greater than Creative Medical Technology Holdings, Inc. (-123148.00), less than Aptevo Therapeutics Inc. (8.24M), less than HCW Biologics Inc. (8.02M), greater than Phio Pharmaceuticals Corp. (-4600542.00), greater than Adial Pharmaceuticals, Inc. (-1724361.00), greater than TransCode Therapeutics, Inc. (-7770350.00),
| Company | Enterprise Value | Market cap |
|---|---|---|
| -42010310.00 | $4.46M | |
| 4.56M | $5.10M | |
| -6766398.00 | $2.49M | |
| -12958522.00 | $6.63M | |
| -123148.00 | $5.60M | |
| 8.24M | $10.45M | |
| 8.02M | $2.67M | |
| -4600542.00 | $12.43M | |
| -1724361.00 | $2.86M | |
| -7770350.00 | $5.07M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kiora Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Kiora Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Kiora Pharmaceuticals, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Kiora Pharmaceuticals, Inc. (KPRX)?
What is the 3-year average Enterprise Value for Kiora Pharmaceuticals, Inc. (KPRX)?
What is the 5-year average Enterprise Value for Kiora Pharmaceuticals, Inc. (KPRX)?
How does the current Enterprise Value for Kiora Pharmaceuticals, Inc. (KPRX) compare to its historical average?